Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Sanna Bastiano Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Disposed/sold 28,828 options to buy @ $12, valued at $345.9k
Granted 28,828 options to buy @ $0
Disposed/sold 18,500 options to buy @ $15.93, valued at $294.7k
Granted 18,500 options to buy @ $0
Disposed/sold 1,172 options to buy @ $15.93, valued at $18.7k
Granted 1,172 options to buy @ $0
Disposed/sold 18,500 options to buy @ $11.49, valued at $212.6k
Disposed/sold 26,400 options to buy @ $5.195, valued at $137.1k
Granted 26,400 options to buy @ $0
06/02/2023 4 Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Granted 5,900 shares @ $0
Granted 26,400 options to buy @ $5.195, valued at $137.1k
05/09/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 422 shares @ $350.03, valued at $147.7k
Sold 2,850 shares @ $350, valued at $997.5k
05/08/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 144 Form 144 - Report of proposed sale of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 211 shares @ $314.22, valued at $66.3k
Sold 94 shares @ $315.66, valued at $29.7k
Sold 90 shares @ $316.76, valued at $28.5k
Sold 96 shares @ $317.65, valued at $30.5k
Sold 31 shares @ $318.68, valued at $9.9k
04/04/2023 144 Form 144 - Report of proposed sale of securities:
04/04/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,466 shares @ $313.74, valued at $459.9k
03/20/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,482 shares @ $300.54, valued at $745.9k
Sold 264 shares @ $301.07, valued at $79.5k
03/16/2023 144 Form 144 - Report of proposed sale of securities:
02/28/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 3,970 shares @ $289.12, valued at $1.1M
02/22/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 3,750 shares @ $292.85, valued at $1.1M
02/14/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 902 shares @ $294.33, valued at $265.5k
Paid exercise price by delivering 4,340 shares @ $298.26, valued at $1.3M
Sold 113 shares @ $300.39, valued at $33.9k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 768 shares @ $312.84, valued at $240.3k
Sold 56 shares @ $310.1, valued at $17.4k
Sold 39 shares @ $311.17, valued at $12.1k
Sold 100 shares @ $312.4, valued at $31.2k
Sold 81 shares @ $313.37, valued at $25.4k
Sold 12 shares @ $314.43, valued at $3.8k
Sold 10 shares @ $315.68, valued at $3.2k
Sold 22 shares @ $317.77, valued at $7k
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 766 shares @ $276.62, valued at $211.9k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 20 shares @ $255.47, valued at $5.1k
Sold 90 shares @ $257.49, valued at $23.2k
Sold 43 shares @ $258.46, valued at $11.1k
Sold 75 shares @ $259.58, valued at $19.5k
Sold 23 shares @ $260.44, valued at $6k
Sold 65 shares @ $261.79, valued at $17k
Sold 4 shares @ $264.37, valued at $1.1k
05/03/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 766 shares @ $276.17, valued at $211.5k
04/08/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 204 shares @ $275.71, valued at $56.2k
Sold 327 shares @ $276.39, valued at $90.4k
Sold 30 shares @ $277.02, valued at $8.3k
04/06/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 305 shares @ $267.1, valued at $81.5k
Sold 257 shares @ $268.43, valued at $69k
Sold 3,163 shares @ $275.23, valued at $870.6k
04/05/2022 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 1,344 shares @ $263.09, valued at $353.6k
03/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 766 shares @ $185.07, valued at $141.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy